DOI QR코드

DOI QR Code

Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves

  • Rajput, Neetu (Department of Pharmacology and Toxicology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University) ;
  • Dumka, Vinod K. (Department of Pharmacology and Toxicology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University) ;
  • Sandhu, Harpal S. (Department of Pharmacology and Toxicology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University)
  • 발행 : 20070300

초록

We investigated the disposition kinetics and urinary excretion of cefpirome in buffalo calves after a single intravenous administration of 10 mg/kg. Also, an appropriate dosage regimen was calculated. At 1 min after injection, the concentration of cefpirome in the plasma was 57.4 ± 0.72 μg/ml, which declined to 0.22 ± 0.01 μg/ml at 24 h. The cefpirome was rapidly distributed from the blood to the tissue compartment as shown by the high distribution coefficient values (8.67 ± 0.46/h), and by the drug’s rate of transfer constant from the central to the peripheral compartment, K12 (4.94 ± 0.31/h). The elimination halflife and the volume of distribution were 2.14 ± 0.02 h and 0.42 ± 0.005 l/kg, respectively. Once the distribution equilibrium was reached between the tissues and plasma, the total body clearance (ClB) and the ratio of the drug present in the peripheral to the central compartment (T/P ratio) were 0.14 ± 0.002 l/kg/h and 1.73 ± 0.06, respectively. Based on the pharmacokinetic parameters we obtained, an appropriate intravenous cefpirome dosage regimen for treating cefpiromesensitive bacteria in buffalo calves would be 8.0 mg/kg repeated at 12 h intervals for 5 days, or until persistence of the bacterial infection occurred.

키워드

과제정보

The senior author duly acknowledges the financial assistance received from Guru Angad Dev Veterinary and Animal Sciences University in the form of a University Merit Scholarship to pursue this study.

참고문헌

  1. Arai S, Kobayashi S, Hayashi S, Sakaguchi T. Distribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch. Antimicrob Agents Chemother 1988, 32, 1396-1399 https://doi.org/10.1128/AAC.32.9.1396
  2. Arret B, Johnson DP, Kirshbaum A. Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci 1971, 60, 1689-1694 https://doi.org/10.1002/jps.2600601122
  3. Bertram MA, Bruckner DA, Young LS. In vitro activity of HR 810, a new cephalosporin. Antimicrob Agents Chemother 1984, 26, 277-279 https://doi.org/10.1128/AAC.26.2.277
  4. Dardi MS, Sharma SK, Srivastava AK. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves. Vet Res Commun 2004, 28, 331-338
  5. Gardner SY, Papich MG. Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. J Vet Pharmacol Ther 2001, 24, 187-192 https://doi.org/10.1046/j.1365-2885.2001.00326.x
  6. Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. pp. 433- 444, Marcel Dekker, New York, 1982
  7. Hancock RE, Bellido F. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. J Antimicrob Chemother 1992, 29 (Suppl A), 1-6 https://doi.org/10.1093/jac/29.1.1
  8. Isert D, Klesel N, Limbert M, Markus A, Seibert G, Schrinner E. Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs. J Antimicrob Chemother 1992, 29 (Suppl A), 31-37 https://doi.org/10.1093/jac/29.suppl_A.31
  9. Jafari HS, Saez-Llorens X, Ramilo O, Shelton SL, McCracken GH Jr. Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis. Antimicrob Agents Chemother 1991, 35, 220-223 https://doi.org/10.1128/AAC.35.2.220
  10. Kavi J, Ashby JP, Wise R, Donovan IA. Intraperitoneal penetration of cefpirome. Eur J Clin Microbiol Infect Dis 1989, 8, 556-558 https://doi.org/10.1007/BF01967480
  11. Kita Y, Yamaaki T, Imada A. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals. Antimicrob Agents Chemother 1992, 36, 2481-2486 https://doi.org/10.1128/AAC.36.11.2481
  12. Klesel N, Seeger K. Pharmacokinetic properties of the new cephalosporin antibiotic HR 810 in animals. Infection 1983, 11, 318-321
  13. Mrestani Y, Bretschneider B, Hartl A, Neubert RHH. Invitro and in-vivo studies of cefpirom using bile salts as absorption enhancers. J Pharm Pharmacol 2003, 55, 1601- 1606 https://doi.org/10.1211/0022357022214
  14. Muller M, Rohde B, Kovar A, Georgopoulos A, Eichler HG, Derendorf H. Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis. J Clin Pharmacol 1997, 37, 1108-1113 https://doi.org/10.1002/j.1552-4604.1997.tb04294.x
  15. Nakanomyo H, Esumi Y, Takaichi M, Seki H, Ninomiya S, Okamura Y, Sudo Y. Study on the pharmacokinetics of cefepime (II). Jap J Antibiot 1992, 45, 938-942
  16. Paradis D, Vallee F, Allard S, Bisson C, Daviau N, Drapeau C, Auger F, LeBel M. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem and ciprofloxacin. Antimicrob Agents Chemother 1992, 36, 2085-2092 https://doi.org/10.1128/AAC.36.10.2085
  17. Rule R, Quiroga GH, Rubio M, Buschiazzo HO, Buschiazzo PM. The pharmacokinetics of ceftazidime in lactating and non-lactating cows. Vet Res Commun 1996, 20, 543-550 https://doi.org/10.1007/BF00396297
  18. Sauermann R, Delle-Karth G, Marsik C, Steiner I, Zeitlinger M, Mayer-Helm BX, Georgopoulos A, Muller M, Joukhadar C. Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother 2005, 49, 650-655 https://doi.org/10.1128/AAC.49.2.650-655.2005
  19. Sharma SK, Srivastava AK. Cefotaxime pharmacokinetics in male buffalo calves following multiple dosing. Vet Arh 2003, 73, 191-197
  20. Wisemann LR, Lamb HM. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs 1997, 54, 117-140 https://doi.org/10.2165/00003495-199754010-00013